XML 92 R79.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 16 - Employee and Non-employee Stock Options (Details Textual) - USD ($)
4 Months Ended 12 Months Ended 24 Months Ended
Mar. 31, 2016
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   0 0    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 40,000     40,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance 40,000 9,182 10,000 40,000 10,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price   $ 0 $ 0    
Delphax [Member] | Certain Employees of Delphax [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,200,000        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0.33        
Employee and Non Employee Director Options [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   0 0    
Allocated Share-based Compensation Expense, Total   $ 0 $ 0    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options   $ 0 $ 0   $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period   818 30,000 6,000 36,000
Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation     $ 63,000    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price   $ 10.56      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance   9,182      
Common Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross   256,000      
Exercise Price to Fair Market Value   100.00%